1. Anti-infection
  2. Bacterial
  3. Narirutin

Narirutin, one of the active constituents isolated from citrus fruits, has antioxidant and anti-inflammatory activities. Narirutin is a shikimate kinase inhibitor with anti-tubercular potency.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

CAS No. : 14259-46-2

사이즈 가격 재고 수량
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
해외재고보유
Solution
10 mM * 1 mL in DMSO 해외재고보유
Solid
1 mg 해외재고보유
5 mg 해외재고보유
10 mg 해외재고보유
20 mg 해외재고보유
50 mg   견적 받기  
100 mg   견적 받기  

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

고객리뷰

Based on 5 publication(s) in Google Scholar

Other Forms of Narirutin:

Top Publications Citing Use of Products

    Narirutin purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2023 Oct:166:115350.  [Abstract]

    Alanine transaminase (ALT) and aspartate transaminase (AST) activity in zebrafish larvae after alcoholic injury with or without Narirutin (NRT) (10, 40 μM) treatment.

    Narirutin purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2023 Oct:166:115350.  [Abstract]

    Real-time PCR analysis of the mRNA levels of inflammatory response genes treated with Narirutin (NRT) (40 μM).

    Narirutin purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2023 Oct:166:115350.  [Abstract]

    Oil-Red O staining was used to detect hepatic lipid accumulation in response to Narirutin (NRT) (10, 40 μM) treatment in zebrafish larvae.

    Narirutin purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2023 Oct:166:115350.  [Abstract]

    Protein expression levels of Ddit3, Bip and Gapdh. Quantification of band intensity of Ddit3 and Bip was calculated by Gadph as a housekeeping protein treated with Narirutin (NRT) (40 μM).
    • Biological Activity

    • 순도&문서

    • References

    • 고객리뷰

    제품 설명

    Narirutin, one of the active constituents isolated from citrus fruits, has antioxidant and anti-inflammatory activities. Narirutin is a shikimate kinase inhibitor with anti-tubercular potency[1][2].

    Cellular Effect
    Cell Line Type Value Description References
    Monocyte IC50
    >200 3
    Compound: Narirutin
    Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA
    Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA
    [PMID: 10096854]
    Monocyte IC50
    > 200 3
    Compound: Narirutin
    Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA
    Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA
    [PMID: 10096854]
    Monocyte IC50
    > 200 3
    Compound: Narirutin
    Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA
    Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA
    [PMID: 10096854]
    In Vitro

    Narirutin (200 μM, 20 h) has no effect on the vitality of RBL-2H3 cells[3].
    Narirutin (25 μM, 2.5 h) inhibits β-hex, histamine, IL-4 and TNF-a release were lower than 40% in RBL-2H3 cells. [3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Narirutin (10 mg/kg, p.o ) reduces eosinophil counts in peripheral blood in OVA-challenged mice[2].
    Narirutin (10 mg/kg, p.o ) block the OVA-induced increase in IL-4 but has no effect on the increase in IL-5 [2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Allergic asthma female NC/Nga mice model[2]
    Dosage: 0.1, 1 or 10 mg/kg
    Administration: Orally, 7d
    Result: Reduced eosinophil counts in peripheral blood.
    Blocked the OVA-induced increase in IL-4.
    Clinical Trial
    분자량

    580.53

    화학식

    C27H32O14

    CAS No.
    Appearance

    Solid

    Color

    White to light yellow

    SMILES

    O=C(C[C@@H](C1=CC=C(O)C=C1)OC2=CC(O[C@@H]([C@@H]([C@@H](O)[C@@H]3O)O)O[C@@H]3CO[C@H](O[C@@H](C)[C@H](O)[C@H]4O)[C@@H]4O)=C5)C2=C5O

    Structure Classification
    Initial Source
    선적

    Room temperature in continental US; may vary elsewhere.

    보관

    4°C, sealed storage, away from moisture and light

    *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

    용액&용해도
    In Vitro: 

    H2O : ≥ 100 mg/mL (172.26 mM)

    DMSO : 100 mg/mL (172.26 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.7226 mL 8.6128 mL 17.2256 mL
    5 mM 0.3445 mL 1.7226 mL 3.4451 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • 몰농도 계산기

    • 농도 희석 계산기

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: 2.08 mg/mL (3.58 mM); Clear solution; Need ultrasonic

      This protocol yields a clear solution of 2.08 mg/mL.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.08 mg/mL (3.58 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  50% PEG300    50% Saline

      Solubility: 10 mg/mL (17.23 mM); Clear solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).
    순도&문서

    Purity: 99.95%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    H2O / DMSO 1 mM 1.7226 mL 8.6128 mL 17.2256 mL 43.0641 mL
    5 mM 0.3445 mL 1.7226 mL 3.4451 mL 8.6128 mL
    10 mM 0.1723 mL 0.8613 mL 1.7226 mL 4.3064 mL
    15 mM 0.1148 mL 0.5742 mL 1.1484 mL 2.8709 mL
    20 mM 0.0861 mL 0.4306 mL 0.8613 mL 2.1532 mL
    25 mM 0.0689 mL 0.3445 mL 0.6890 mL 1.7226 mL
    30 mM 0.0574 mL 0.2871 mL 0.5742 mL 1.4355 mL
    40 mM 0.0431 mL 0.2153 mL 0.4306 mL 1.0766 mL
    50 mM 0.0345 mL 0.1723 mL 0.3445 mL 0.8613 mL
    60 mM 0.0287 mL 0.1435 mL 0.2871 mL 0.7177 mL
    80 mM 0.0215 mL 0.1077 mL 0.2153 mL 0.5383 mL
    100 mM 0.0172 mL 0.0861 mL 0.1723 mL 0.4306 mL

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    최근 본 상품:

    온라인 문의

    Your information is safe with us. * Required Fields.

    상품명

     

    Requested Quantity *

    고객명 *

     

    호칭

    메일주소 *

     

    전화번호 *

    Department

     

    회사명 *

    City

    Country or Region *

         

    비고

    대량구매 문의

    Inquiry Information

    상품명:
    Narirutin
    Cat. No.:
    HY-N0804
    수량:
    MCE Japan Authorized Agent: